{"id":985912,"date":"2026-07-28T16:27:08","date_gmt":"2026-07-28T20:27:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/"},"modified":"2026-07-28T16:27:08","modified_gmt":"2026-07-28T20:27:08","slug":"veracyte-to-participate-in-upcoming-investor-conferences-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/","title":{"rendered":"Veracyte to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., July  28, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ObY8rwQr6TZJ79tITGuTpurwovJ5vcB8X374YkdRnK8rWye9gWYyByBJh7qnvIYMvZxlFgHIlt97XCItyrmkXeECyX5hhNdy2fg9nq7y6co=\" rel=\"nofollow\" target=\"_blank\">Veracyte, Inc.<\/a> (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Canaccord Genuity 46<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Growth Conference \u2013 Boston, MA<br \/><\/strong>Fireside chat on Tuesday, Aug 11<sup>th<\/sup> at 10:30 a.m. Eastern Time<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Morgan Stanley 24<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Healthcare Conference \u2013 New York, NY<br \/><\/strong>Fireside chat on Tuesday, Sep 15<sup>th<\/sup> at 5:35 p.m. Eastern Time<\/p>\n<\/li>\n<\/ul>\n<p>Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CA4p8XQ_eB-Wy9io1rT70VgMCaUxRQkfRKW73Ou_cYLb6_jO6oPNHyyzTlpqMQX30JoJTzyHFArFEstjy-6nh6ZpDC1Q3hVzmT7nSFCvbON886U4n7Nmo14516Dmpi0GS061o5ZZ770FhbfynPfXCjBe4y7IE-69tjLrPZ6s3IA=\" rel=\"nofollow\" target=\"_blank\">http:\/\/investor.veracyte.com\/events-presentations<\/a>. Replays of the webcasts will be available for 90 days after each live presentation broadcast.<\/p>\n<p>\n        <strong>About\u00a0Veracyte<\/strong>\n      <\/p>\n<p>Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for patients around the world. The company\u2019s molecular tests assess the unique biology of each patient\u2019s tumor to help clinicians answer essential questions about cancer care.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ObY8rwQr6TZJ79tITGuTphMA_CUR5OJEuwyrIsiQr5Ry8vrN75qAIcECifYWmDMPGG-SCmohzOVkgyiomhTDrQVuNHLbsCqTVg1xWTT6PL0K45lmSuywPXURnLF0jfTeax8gWAKTRsHd_lpFfOrCBvqsFKiO1kXLMalfmnOCqfo=\" rel=\"nofollow\" target=\"_blank\">Veracyte\u2019s Diagnostics Platform<\/a> combines broad genomic and clinical data, advanced bioinformatics and AI, and a powerful evidence-generation engine to support continued <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wawY9gGUcsGsVT0lN2xeOueiK749nxWhoKHxAb0mV6zM2iMZFmY1LLGHEi1aJQ-bs0GBS4TJy1M9rwZzoMCLd0hYQvM5eTDvqI2cizDZ3LT1dux-vjvXbF7HOttGArGGnHXR1YESVq_AWXLmXiSRn67Xa2amnR9wNTUGhTlUGDw=\" rel=\"nofollow\" target=\"_blank\">innovation and pipeline development<\/a>. The company\u2019s portfolio includes the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eoqyS6rFTA6yIiwtu_1O9ymmGKxhfHpCWDN7Fr0VmCsH0JbMfbxET5a6FILOLeHn_rI32abqkcL8JFK4jydgEWmJTipbDWBQSPCmjfT2LvlwMz3LXJfasXA84MFnQp0XZhXH4h5pvmjNt1_4o3BK5dQKHY0E9trh6ysHxBNujL4=\" rel=\"nofollow\" target=\"_blank\">Afirma\u00ae Genomic Sequencing Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G1hvmrGGPWz8RMPrK_DDb3Zvrxb-aeQgpZjOp6iSUvPzlb59dQGMqT7BavkGNUL0gWdDqUtDJNP4tG4exEtXp8--P-dfoeR5JiZjZfmgNALhRepoyiSv-FHil8eXQsth1O4YXBQo3Rtk6bzlgaKbOq3dlXY-OtOMgQrCcV_COz8=\" rel=\"nofollow\" target=\"_blank\">Decipher\u00ae Bladder Genomic Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G1hvmrGGPWz8RMPrK_DDb8V-p9on6toKmGKGow1ih8ivXpYZDqaEnyaUFAq_eQ1ZUIyVBIE-Lt-ljKZVBnExdFmFFiWcW2d3FurPBaWeg_Iw43iWD1sx4bSiWhqAAWfC3tHvrM4f6fBs2Rl6assOmZYsleWsnSOC26kYEmKDqgU=\" rel=\"nofollow\" target=\"_blank\">Decipher\u00ae Prostate Genomic Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=coPYSBpgFeCU_eCXY3XsGcIwx9hcIXZXcRrPMrcV9yAB-JkMMH-FsOP7-9pZ7FkDzunM5c3ulIaROABKSqXkLnZon0s4S1aesQ-BTjdEc3VuQYoR1oR-z9U0zu4Pz_l4fNs4t-Q92M5jq-0lS5oQo_3xcrqJQYA9co5V575S-UY=\" rel=\"nofollow\" target=\"_blank\">Prosigna\u00ae Breast Risk of Recurrence test<\/a>, and the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Qh5aou-6daE6JACdC_PUflWYkOWdXMhNiRICJxz2e0s9DHvXVz2xtE_QNs2StBFPlU5koe8hd3mEoSu5oYU5_xap8ZI3Vr-WxvwhP8R4iS9dn7aavGju5FaAJftIStuJhY0H0NL5Ymcq-NVuyQ9GFw==\" rel=\"nofollow\" target=\"_blank\">TrueMRD\u2122 Monitoring Test for MIBC<\/a>. For more information, visit Veracyte\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YkC28dLY9oRZ9s22OynzpYvfnHxxfzn6C4CX_Ac1Q--3DgzfQnl_dA9W7S9SmpXFe0FqX254ZYYMskBV9xwU-A==\" rel=\"nofollow\" target=\"_blank\">website<\/a>\u00a0or follow the company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jr8Ey9AZNDo26ZfGff24q_nyRWlgQTW4lgZx-BPQWPYC7eOBPg9ugfsXezlqkAUGp3aMm5eFvAF0w1PFITzxoU8_uN-mN1NzzH343FKCfsE=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dqj-2XQVCHyTUh9tBW_gg51iR2SnC_53uH51R2f6YVOVO1_d4vB5wmxe3-okILm4hlatfIIAayvrxjUJUBKQ1g==\" rel=\"nofollow\" target=\"_blank\">X (Twitter)<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDdiNzI2ZDQtYWJkYS00ZmQ3LWExNmQtYzUwYjRhZjRiYWYyLTEwMTgyNjEtMjAyNi0wNy0yOC1lbg==\/tiny\/Veracyte-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investors:\r\nKelly Gura\r\ninvestors@veracyte.com\r\n\r\nMedia:\r\nMolly Cornbleet\r\nmedia@veracyte.com\r\n+1-650-351-8780<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences: Canaccord Genuity 46 th Annual Growth Conference \u2013 Boston, MAFireside chat on Tuesday, Aug 11th at 10:30 a.m. Eastern Time Morgan Stanley 24 th Annual Global Healthcare Conference \u2013 New York, NYFireside chat on Tuesday, Sep 15th at 5:35 p.m. Eastern Time Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at http:\/\/investor.veracyte.com\/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast. About\u00a0Veracyte Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Veracyte to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-985912","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences: Canaccord Genuity 46 th Annual Growth Conference \u2013 Boston, MAFireside chat on Tuesday, Aug 11th at 10:30 a.m. Eastern Time Morgan Stanley 24 th Annual Global Healthcare Conference \u2013 New York, NYFireside chat on Tuesday, Sep 15th at 5:35 p.m. Eastern Time Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at http:\/\/investor.veracyte.com\/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast. About\u00a0Veracyte Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for &hellip; Continue reading &quot;Veracyte to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-28T20:27:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Veracyte to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-07-28T20:27:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/\"},\"wordCount\":233,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/\",\"name\":\"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=\",\"datePublished\":\"2026-07-28T20:27:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-participate-in-upcoming-investor-conferences-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veracyte to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/","og_locale":"en_US","og_type":"article","og_title":"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences: Canaccord Genuity 46 th Annual Growth Conference \u2013 Boston, MAFireside chat on Tuesday, Aug 11th at 10:30 a.m. Eastern Time Morgan Stanley 24 th Annual Global Healthcare Conference \u2013 New York, NYFireside chat on Tuesday, Sep 15th at 5:35 p.m. Eastern Time Live audio webcasts of the company\u2019s presentations will be available by visiting Veracyte\u2019s website at http:\/\/investor.veracyte.com\/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast. About\u00a0Veracyte Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for &hellip; Continue reading \"Veracyte to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-28T20:27:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Veracyte to Participate in Upcoming Investor Conferences","datePublished":"2026-07-28T20:27:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/"},"wordCount":233,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/","name":"Veracyte to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=","datePublished":"2026-07-28T20:27:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc5OTUyMyM3NzQ3MjM0IzIwMDY2ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-participate-in-upcoming-investor-conferences-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Veracyte to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/985912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=985912"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/985912\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=985912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=985912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=985912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}